FDA Inspection
BLS Labs, LLCBLS Labs, LLC – FDA Inspection, Feb 9, 2024
Record Details
This FDA Inspection record concerns BLS Labs, LLC, with an inspection on February 9, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7eb4579e-5156-480b-b8fb-d44d6f7b5610
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229004
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
16- 21 CFR 1271.290(e)Documenting disposition of each HCT/P
- 21 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 1271.190(d)(1)Description of methods, schedule
- 21 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 211.113(b)Procedures for sterile drug products
Showing 10 of 16 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BLS Labs, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2021 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for BLS Labs, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.